Autopsy report · NCT01195103

Lusedra (Fospropofol Disodium) for Minimal to Moderate Sedation for Regional Anesthesia Block Prior to Orthopedic Surgery

“Funding terminated by funding source.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 5 months before it started.
• Ran for about 1 month before it stopped.
• 13 participants enrolled.
• Results were posted on the registry 1 year after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Mayo Clinic

Sponsor type

University, hospital or other

Conditions

Procedural Sedation; Regional Anesthesia Block; Orthopedic Surgery

Interventions

Fospropofol disodium; Fospropofol disodium; Placebo + Midazolam; Fentanyl

Participants

13

Sites

1

Countries

United States

Trials that died the same way

• Differential Gene Expression in Lung and Peripheral Blood After Inhaled Allergen Challenge
  “funding terminated” (91% match in meaning)
• The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations
  “Funding was terminated” (89% match in meaning)
• Predictors of Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis
  “Souces of funding have been terminated” (86% match in meaning)
• Success of Long-acting Anti-inflammatories After Anterior Cruciate Ligament and Meniscal Injury
  “Funding Termination” (84% match in meaning)
• Mindfulness Intervention for Caregivers of Autism in Rural Environments
  “Funding was terminated, seeing new funding.” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.